126 related articles for article (PubMed ID: 19641653)
1. Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice.
Takada H; Kishimoto C; Kurokawa M; Hiraoka Y
Exp Clin Cardiol; 2003; 8(2):71-5. PubMed ID: 19641653
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide differences of coxsackievirus B3 and chronic myocarditis.
Kishimoto C; Takamatsu N; Ochiai H; Kuribayashi K
Heart Vessels; 2015 Jan; 30(1):126-35. PubMed ID: 24493328
[TBL] [Abstract][Full Text] [Related]
3. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants.
Gómez RM; Cui X; Castagnino CG; Berría MI
Intervirology; 1993; 36(3):153-60. PubMed ID: 8150596
[TBL] [Abstract][Full Text] [Related]
4. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3.
Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ
J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.
Huber SA; Graveline D; Born WK; O'Brien RL
J Virol; 2001 Jul; 75(13):5860-9. PubMed ID: 11390587
[TBL] [Abstract][Full Text] [Related]
8. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
Kishimoto C; Abelmann WH
Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
[TBL] [Abstract][Full Text] [Related]
9. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood.
Kishimoto C; Misaki T; Crumpacker CS; Abelmann WH
Circulation; 1988 Mar; 77(3):645-53. PubMed ID: 2830046
[TBL] [Abstract][Full Text] [Related]
10. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
Huber S; Song WC; Sartini D
Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
[TBL] [Abstract][Full Text] [Related]
11. Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis.
Huber SA
Immunology; 2009 Aug; 127(4):567-76. PubMed ID: 19604307
[TBL] [Abstract][Full Text] [Related]
12. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice.
Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
J Nutr; 1994 Mar; 124(3):345-58. PubMed ID: 8120653
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
Kishimoto C; Kurokawa M; Ochiai H
J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
[TBL] [Abstract][Full Text] [Related]
16. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.
Gauntt CJ; Trousdale MD; LaBadie DR; Paque RE; Nealon T
J Med Virol; 1979; 3(3):207-20. PubMed ID: 225441
[TBL] [Abstract][Full Text] [Related]
17. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
Henke A; Huber S; Stelzner A; Whitton JL
J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
[TBL] [Abstract][Full Text] [Related]
19. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells.
Huber SA; Sartini D; Exley M
J Virol; 2002 Nov; 76(21):10785-90. PubMed ID: 12368321
[TBL] [Abstract][Full Text] [Related]
20. An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency mouse.
Kishimoto C; Hiraoka Y; Takamatsu N; Takada H; Kamiya H; Ochiai H
Cardiovasc Res; 2003 Nov; 60(2):397-403. PubMed ID: 14613869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
